Olema Pharmaceuticals, Inc. (OLMA)
9.82
-0.08
(-0.81%)
USD |
NASDAQ |
Sep 18, 16:00
9.82
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Price : 9.82 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 9.88 | 9.93 | 9.75 | 9.82 | 3.061M |
| Sep 17, 2026 | 9.89 | 10.35 | 9.73 | 9.90 | 1.088M |
| Sep 16, 2026 | 9.86 | 9.93 | 9.44 | 9.73 | 1.248M |
| Sep 15, 2026 | 10.29 | 10.34 | 9.65 | 9.78 | 1.733M |
| Sep 14, 2026 | 9.99 | 10.37 | 9.79 | 10.29 | 1.823M |
| Sep 11, 2026 | 10.79 | 10.86 | 10.18 | 10.22 | 1.013M |
| Sep 10, 2026 | 10.19 | 10.98 | 10.11 | 10.69 | 1.116M |
| Sep 09, 2026 | 11.13 | 11.18 | 10.35 | 10.36 | 863843.0 |
| Sep 08, 2026 | 10.61 | 11.06 | 10.46 | 10.98 | 736717.0 |
| Sep 04, 2026 | 10.61 | 10.85 | 10.57 | 10.75 | 505266.0 |
| Sep 03, 2026 | 10.71 | 10.98 | 10.58 | 10.73 | 773317.0 |
| Sep 02, 2026 | 10.58 | 11.02 | 10.48 | 10.83 | 866429.0 |
| Sep 01, 2026 | 10.36 | 10.63 | 10.28 | 10.56 | 766112.0 |
| Aug 31, 2026 | 10.20 | 10.53 | 10.09 | 10.43 | 937028.0 |
| Aug 28, 2026 | 10.69 | 10.77 | 10.19 | 10.27 | 740849.0 |
| Aug 27, 2026 | 10.70 | 10.92 | 10.62 | 10.79 | 383348.0 |
| Aug 26, 2026 | 10.78 | 10.96 | 10.58 | 10.85 | 472336.0 |
| Aug 25, 2026 | 10.60 | 11.02 | 10.60 | 10.91 | 799924.0 |
| Aug 24, 2026 | 10.58 | 10.62 | 10.29 | 10.43 | 727325.0 |
| Aug 21, 2026 | 10.90 | 11.24 | 10.65 | 10.69 | 748704.0 |
| Aug 20, 2026 | 11.10 | 11.12 | 10.67 | 10.90 | 1.039M |
| Aug 19, 2026 | 10.90 | 11.36 | 10.76 | 11.31 | 1.758M |
| Aug 18, 2026 | 10.69 | 10.88 | 10.51 | 10.65 | 960519.0 |
| Aug 17, 2026 | 10.61 | 10.95 | 10.51 | 10.77 | 889851.0 |
| Aug 14, 2026 | 10.44 | 10.75 | 10.29 | 10.63 | 1.163M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.49 |
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
Price Related Metrics
| PEG Ratio | -0.4565 |
| Price to Book Value | 1.994 |
| Earnings Yield | -21.57% |
| Market Cap | 858.78M |
| PEGY Ratio | -0.4565 |